Sign in

CIK 0001816736

  • Large accelerated filer

Disc Medicine, Inc.

Sign in to watch
Ticker
IRON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
851612845
Phone
+1 617-674-9274
Business address
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
Former names
Gemini Therapeutics, Inc. /DE, FS Development Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,877,065
in 6 filings, $10.0M under 10b5-1 plans

Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 32 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-22 Khara Rahul General Counsel Option exercise 10b5-1 +10,000 $14.69 $147K 10,000
2023-11-22 Khara Rahul General Counsel Sale 10b5-1 −100 $50.34 $5K 9,900
2023-11-22 Khara Rahul General Counsel Sale 10b5-1 −9,900 $51.75 $512K 0
2023-11-22 Khara Rahul General Counsel Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 79,804
2023-11-15 Khara Rahul General Counsel Option exercise · Stock Option (Right to Buy) 10b5-1 −4,900 89,804
2023-11-14 Khara Rahul General Counsel Option exercise 10b5-1 +4,900 $14.69 $72K 4,900
2023-11-14 Khara Rahul General Counsel Sale 10b5-1 −4,113 $50.53 $208K 787
2023-11-14 Khara Rahul General Counsel Sale 10b5-1 −787 $51.05 $40K 0
2023-11-03 Khara Rahul General Counsel Option exercise 10b5-1 +100 $14.69 $1K 100
2023-11-03 Khara Rahul General Counsel Sale 10b5-1 −100 $50.00 $5K 0
2023-11-03 Khara Rahul General Counsel Option exercise · Stock Option (Right to Buy) 10b5-1 −100 94,704
2023-09-16 Atlas Venture Fund X, L.P. 10% owner Sale −2,115 $53.22 $113K 1,593,785
2023-09-15 Atlas Venture Fund X, L.P. 10% owner Sale −260,894 $53.16 $13.9M 1,595,900
2023-09-14 Atlas Venture Fund X, L.P. 10% owner Sale −94,440 $53.05 $5.0M 1,856,794
2023-09-11 Bryce Joanne Chief Financial Officer Option exercise +2,500 $9.86 $25K 3,760
2023-09-11 Bryce Joanne Chief Financial Officer Option exercise · Stock Option (Right to Buy) −2,500 76,745
2023-09-01 Bryce Joanne Chief Financial Officer Option exercise 10b5-1 +1,000 $2.65 $3K 2,260
2023-09-01 Bryce Joanne Chief Financial Officer Sale 10b5-1 −1,000 $52.99 $53K 1,260
2023-09-01 Bryce Joanne Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −1,000 3,753
2023-08-21 Savage William Jacob Chief Medical Officer Option exercise +3,000 $2.65 $8K 3,000

Page 28 of 32 · 639 trades